In the U.S. in the early 1960s the distributor of a thalidomide drug was impatient to get it on the market. But FDA medical ...

23andMe 's independent directors resigned, citing lack of an actionable proposal for non-affiliated shareholders as Chief Executive Anne Wojcicki seeks to take the company private ... that if central ...

All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that have ...

All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne ...

The directors had formed a special committee in March tasked with helping the struggling company find a new path forward. In a memo to employees, CEO Anne Wojcicki said she was "surprised and ...

In April, Anne Wojcicki started contemplating taking the genetics testing company private. Founded in 2006, 23andMe went public in 2021 via a merger with a special purpose acquisition company ...